Remote Ischemic Conditioning in Pulmonary Fibrosis
A study on mice indicates that remote ischemic conditioning can reduce pulmonary fibrosis pathology caused by diesel exhaust. The intervention improved physiological markers and reduced inflammation, suggesting potential as a non-pharmacological treatment for lung disease.
Why it matters
This research offers a potential new, non-invasive therapeutic approach for treating pulmonary fibrosis, a serious and often progressive lung condition.
REMOTE ischemic conditioning significantly reduced pulmonary fibrosis pathology in a diesel exhaust-induced mouse model, improving physiological measures, lowering inflammatory and fibrotic markers, and restoring mitochondrial health.
These findings suggest that this non-pharmacological intervention could have therapeutic potential in pulmonary fibrosis.
Researchers evaluated remote ischemic conditioning in mice with pulmonary fibrosis induced by prolonged diesel exhaust exposure.
The intervention was delivered either before or during disease development and was compared with both untreated disease and treatment with pirfenidone.
Across multiple physiological and molecular assessments, mice receiving remote ischemic conditioning demonstrated clear improvements compared with untreated animals.
Body weight and heart rate variability, both adversely affected by diesel exhaust exposure, improved in groups receiving the intervention.
Histopathological analysis also revealed reduced cellular infiltration, less bronchiolar inflammation, and fewer structural abnormalities within lung tissue.
These changes indicated attenuation of key pulmonary fibrosis features.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in